Km. Thompson et al., VARIABLE REGION GENE USAGE OF HUMAN MONOCLONAL RHEUMATOID FACTORS DERIVED FROM HEALTHY DONORS FOLLOWING IMMUNIZATION, European Journal of Immunology, 24(8), 1994, pp. 1771-1778
A study was performed to compare the use of immunoglobulin V gene segm
ents by rheumatoid factors (RF) produced in physiological responses fo
llowing a defined antigenic stimulus, with RF produced in rheumatoid a
rthritis (RA) and RF produced as monoclonal (M)-components in certain
lympho-proliferative diseases. A panel of 46 monoclonal RF was produce
d, using hybridoma techniques, from healthy individuals following immu
nization with foreign antigens (mis-matched red blood cells). A panel
of previously characterized monoclonal RF from RA synovial tissues was
extended to a total of 24 and included in the study. The variable hea
vy (V-H) and variable light (V-L) chain gene families used by these RF
were determined using idiotypic markers and polymerase chain reaction
amplification with V-H-specific primers. The frequencies of expressio
n of the various gene families was compared between the two groups, an
d compared with the published expression frequencies seen amongst M-co
mponent RE The majority (87 %) of RF from healthy donors were found wi
th light chains using V gene segments of the V kappa 3 family, in conj
unction with VH gene segments belonging to the V(H)1,V(H)3 and V(H)4 f
amilies. The over-expression of V kappa 3, together with the distribut
ion of V-H families, demonstrates close similarities with RF found as
M-components in lympho-proliferative diseases. In contrast, RF from RA
patients showed a predominant use of V(H)3 gene segments (82 %) and a
n unbiased expression of V kappa 3 segments (29 % of the kappa light c
hains). These data suggest that RF found as M-components are represent
ative of RF used in normal physiological responses, but have undergone
neoplastic or other transformation. RF found in the synovial tissue o
f RA patients appear to be driven by different mechanisms than RF seen
in physiological responses in healthy individuals.